Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Enanta Pharmaceuticals(US:ENTA) Seeking Alpha·2026-01-15 01:25Company Overview - Enanta is a virology and immunology company with a historical focus on hepatitis C, having developed two products in collaboration with AbbVie, including glecaprevir, which is part of the hepatitis C drug MAVYRET that has cured over 1 million patients with chronic hepatitis C [3]. Current Focus - The company has expanded its focus beyond liver virology to respiratory virology, with respiratory syncytial virus (RSV) as its first target, addressing a significant unmet medical need as no safe and effective treatment has been developed for this virus despite its characterization over six decades [4].